Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: A container seal device is provided that comprises a seal device for a shipping container, comprising a first unit that is affixed to a shipping container. A control system is contained in the first unit containing a control system. A second unit is provided that is configured to engage with an element of a door of a shipping container to which the first unit is affixed and to electrically connect with the control system in the first unit. The control system in the first unit is configured to detect a breach of the second unit indicative of access being made to the shipping container.

Abstract: The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Abstract: A container seal device is provided that comprises a seal device for a shipping container, comprising a first unit that is affixed to a shipping container. A control system is contained in the first unit containing a control system. A second unit is provided that is configured to engage with an element of a door of a shipping container to which the first unit is affixed and to electrically connect with the control system in the first unit. The control system in the first unit is configured to detect a breach of the second unit indicative of access being made to the shipping container.

Abstract: A container seal device is provided that comprises a seal device for a shipping container, comprising a first unit that is affixed to a shipping container. A control system is contained in the first unit containing a control system. A second unit is provided that is configured to engage with an element of a door of a shipping container to which the first unit is affixed and to electrically connect with the control system in the first unit. The control system in the first unit is configured to detect a breach of the second unit indicative of access being made to the shipping container.

Abstract: An architecture for providing multi-media service to a client includes a web page host server for providing pages of information capable of display by a client browser, and a contact center platform capable of establishing communication between a representative and the client via telephone. At least one of the pages provided by the host server includes an indication of service options available from the contact center platform, and further includes an indication of delay associated with provision of one of those service options. In response to selection of one of the callback options by the customer, the customer is placed in a virtual callback queue in the contact center platform. Selected customer data including phone number is then provided to the contact center platform for use in establishing the callback and providing the customer service representative with information in order to avoid duplicative gathering of particular information.

Abstract: A plug for sealing and resealing the passages for heating and cooling liquid in a casting mold. The plug includes a stainless steel socket head NPT plug which is screwed into the passage to seal it. Inboard of the plug there is mounted a resilient expandable silicone tubular element that is expanded by squeezing it to further seal the passage.

Abstract: A plug for sealing and resealing the passages for heating and cooling liquid in a casting mold. The plug includes a stainless steel socket head NPT plug which is screwed into the passage to seal it. Inboard of the plug there is mounted a resilient expandable silicone tubular element that is expanded by squeezing it to further seal the passage.